78 research outputs found
Grounding sustainable tourism in science—a geographic approach
This paper presents empirical research that supports territorial approaches to tourism product development that ground tourism in science, as a mechanism to support sustainable tourism heritage conservation goals. Scientific Tourism (ST), in this context, builds on the scientific heritage of a geography, matching researchers with local actors and tourists, through a five-stage iterative process that leads to new scientific knowledge, advancing theory and building relevance for communities through socio-cultural and economic development. This article focuses on the initial stage of the ST product development process, documenting empirical research conducted within the geographies surrounding the Palena River watershed in the Aysén Region of Chilean Patagonia. Both geo-structured literature review methods and results are presented and discussed to illustrate how the outcomes, including a series of maps, can inform and ground actors’ processes of heritage resource identification, justification, conservation, and exhibition, through the development of pilot ST initiatives within the territory. Similar research approaches may prove valuable for other low-density and peripheral geographies that share an interest in grounding tourism on the science taking place within their geography
Clinical and Immunopathologic Profile of Mexican Patients with IgG4 Autoimmune Pancreatitis
Autoimmune pancreatitis is part of the spectrum of IgG4-associated diseases. Its diagnostic criteria and histological subtypes have been formally proposed recently and although based on current data it has been suggested that there are differences in clinical presentation among populations, more research is needed to properly establish if this heterogeneity exists. In this paper, we describe 15 cases of autoimmune pancreatitis diagnosed at a Mexican centre of reference, all of them associated to the lymphoplasmocytic sclerosing pancreatitis variant. The mean age at the onset of symptoms was 47.5 ± 14.4 years, and 53% of patients were male. The main manifestations were weight loss (87%), obstructive jaundice (53%), and acute (27%) and chronic (27%) pancreatitis. Only 20% of patients had high IgG4 serum levels at the time of diagnosis. All patients receiving prednisone responded favourably, both in their pancreatic and extrapancreatic manifestations. Clinical manifestations of Mexican patients showed certain differences with respect to those usually reported
Evaluation of drug administration errors in a teaching hospital
<p>Abstract</p> <p>Background</p> <p>Medication errors can occur at any of the three steps of the medication use process: prescribing, dispensing and administration. We aimed to determine the incidence, type and clinical importance of drug administration errors and to identify risk factors.</p> <p>Methods</p> <p>Prospective study based on disguised observation technique in four wards in a teaching hospital in Paris, France (800 beds). A pharmacist accompanied nurses and witnessed the preparation and administration of drugs to all patients during the three drug rounds on each of six days per ward. Main outcomes were number, type and clinical importance of errors and associated risk factors. Drug administration error rate was calculated with and without wrong time errors. Relationship between the occurrence of errors and potential risk factors were investigated using logistic regression models with random effects.</p> <p>Results</p> <p>Twenty-eight nurses caring for 108 patients were observed. Among 1501 opportunities for error, 415 administrations (430 errors) with one or more errors were detected (27.6%). There were 312 wrong time errors, ten simultaneously with another type of error, resulting in an error rate without wrong time error of 7.5% (113/1501). The most frequently administered drugs were the cardiovascular drugs (425/1501, 28.3%). The highest risks of error in a drug administration were for dermatological drugs. No potentially life-threatening errors were witnessed and 6% of errors were classified as having a serious or significant impact on patients (mainly omission). In multivariate analysis, the occurrence of errors was associated with drug administration route, drug classification (ATC) and the number of patient under the nurse's care.</p> <p>Conclusion</p> <p>Medication administration errors are frequent. The identification of its determinants helps to undertake designed interventions.</p
Graphene Transistor as a Probe for Streaming Potential
We explore the dependence of electrical transport in a graphene field effect
transistor (GraFET) on the flow of the liquid within the immediate vicinity of
that transistor. We find large and reproducible shifts in the charge neutrality
point of GraFETs that are dependent on the fluid velocity and the ionic
concentration. We show that these shifts are consistent with the variation of
the local electrochemical potential of the liquid next to graphene that are
caused by the fluid flow (streaming potential). Furthermore, we utilize the
sensitivity of electrical transport in GraFETs to the parameters of the fluid
flow to demonstrate graphene-based mass flow and ionic concentration sensing.
We successfully detect a flow as small as~70nL/min, and detect a change in the
ionic concentration as small as ~40nM.Comment: 6 pages, 4 figure
Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe
Purpose: In the accompanying article, “Analysis of Fertility Preservation Options Available to Patients With Cancer Around the Globe,” we showed that specific fertility preservation services may not be offered at various sites around the world because of cultural and legal barriers. We assessed global and regional experiences as well as the legal status of third-party reproduction and adoption to serve as a comprehensive international data set and resource for groups that wish to begin oncofertility interventions. Methods: We provide data on the legalities of third-party assisted reproductive technologies and other family-building options in the 28 oncofertility-practicing countries surveyed. Results: We found regional and country differences that will be important in the development of tailored resources for physicians and for patient brochures that are sensitive to these local restrictions and cultural norms. Conclusion: Because many patients first consult Web-based materials, the formal assessment of the availability of these options provides members of the global oncofertility community with data to which they might otherwise not have ready access to better serve their patients
Survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe
bstract
PURPOSE In the accompanying article, “Survey of Fertility Preservation Options Available to Patients With Cancer
Around the Globe,” we showed that specific fertility preservation services may not be offered at various sites
around the world because of cultural and legal barriers. We assessed global and regional experiences as well as
the legal status of third-party reproduction and adoption to serve as a comprehensive international data set and
resource for groups that wish to begin oncofertility interventions.
METHODS We provide data on the legalities of third-party assisted reproductive technologies and other familybuilding options in the 28 oncofertility-practicing countries surveyed.
RESULTS We found regional and country differences that will be important in the development of tailored
resources for physicians and for patient brochures that are sensitive to these local restrictions and
cultural norms.
CONCLUSION Because many patients first consult Web-based materials, the formal assessment of the availability
of these options provides members of the global oncofertility community with data to which they might otherwise
not have ready access to better serve their patients
A View from the Past Into our Collective Future: The Oncofertility Consortium Vision Statement
Today, male and female adult and pediatric cancer patients, individuals transitioning between gender identities, and other individuals facing health extending but fertility limiting treatments can look forward to a fertile future. This is, in part, due to the work of members associated with the Oncofertility Consortium. The Oncofertility Consortium is an international, interdisciplinary initiative originally designed to explore the urgent unmet need associated with the reproductive future of cancer survivors. As the strategies for fertility management were invented, developed or applied, the individuals for who the program offered hope, similarly expanded. As a community of practice, Consortium participants share information in an open and rapid manner to addresses the complex health care and quality-of-life issues of cancer, transgender and other patients. To ensure that the organization remains contemporary to the needs of the community, the field designed a fully inclusive mechanism for strategic planning and here present the findings of this process. This interprofessional network of medical specialists, scientists, and scholars in the law, medical ethics, religious studies and other disciplines associated with human interventions, explore the relationships between health, disease, survivorship, treatment, gender and reproductive longevity. The goals are to continually integrate the best science in the service of the needs of patients and build a community of care that is ready for the challenges of the field in the future
O gerenciamento das inter-relações da produção agrícola com o meio ambiente a partir das bacias hidrográficas: um ensaio compreensivo
Surgical treatment of primitive ventricle and complex congenital heart malformation with total exclusion of the right heart: Report of a case
Isovolumic contraction time of right ventricle in d-transposition of great arteries.
International audienceThe pre-ejection period of the right ventricle in d-transposition of the great arteries is known to be prolonged, compared with the same interval of the left ventricle of normal subjects. In the present study, the echocardiographic measurement of the components of the pre-ejection period of the right ventricle of 14 patients with d-transposition of the great arteries shows that the isometric contraction time of the right ventricle in d-transposition of the great arteries is similar to the same interval calculated on the left ventricle of 76 normal children of comparable age. On the other hand, the electromechanical delay was significantly greater for the right ventricle of d-transposition of the great arteries than for the left ventricle of the normal subjects. It is concluded that the prolonged pre-ejection period of the right ventricle in d-transposition of the great arteries is not the result of right ventricular dysfunction but solely of a longer electromechanical delay
- …